Document Detail


Dolichol delays G1-arrest for one cell cycle in human fibroblasts subjected to depletion of serum or mevalonate.
MedLine Citation:
PMID:  1487489     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
It is well-established that some product(s) or metabolite(s) of mevalonate is (are) critical for growth of mammalian cells. In the search for this (these) compound(s) it seems meaningful to distinguish between compounds needed for cell cycle progression in proliferating cells and compounds needed for growth activation of arrested cells. By using time-lapse video recording we have studied the possible regulatory role of cholesterol, dolichol and mevalonate in the cell cycle of human diploid fibroblasts (HDF). HDF, which are serum-dependent, were rapidly growth-arrested in the first part of G1 upon removal of serum factors. They also responded to mevinolin (an HMG CoA reductase inhibitor) by a similar G1-block, indicating that a mevalonate-derived product is involved in the G1-located cell cycle control of HDF. Interestingly, dolichol counteracted the G1-block caused by both types of treatment. Hence, the early G1-cells could traverse the remainder of the cell cycle and divide despite depletion of serum or mevalonate. We also demonstrated that addition of dolichol resulted in a significant decrease in the rate of protein degradation. This protein stabilizing effect may constitute the mechanism by which dolichol delays the G1-arrest of HDF.
Authors:
O Larsson; J Wejde
Related Documents :
1343599 - Calmodulin and cell cycle control.
9018099 - 17beta-estradiol metabolites affect some regulators of the mcf-7 cell cycle.
19589379 - Expression of the neural specific protein, gap-43, dramatically lengthens the cell cycl...
15906259 - The role of men (mitosis exit network) proteins in the cytokinesis of saccharomyces cer...
14967829 - Angiotensin ii and cell cycle regulation.
18203579 - A minimal mathematical model combining several regulatory cycles from the budding yeast...
954079 - Lack of correlation between agglutinability, the surface distribution of con a and post...
12871329 - Endogenous plasmin converts glu-plasminogen to lys-plasminogen on the monocytoid cell s...
21992819 - Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cell science     Volume:  103 ( Pt 4)     ISSN:  0021-9533     ISO Abbreviation:  J. Cell. Sci.     Publication Date:  1992 Dec 
Date Detail:
Created Date:  1993-02-24     Completed Date:  1993-02-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0052457     Medline TA:  J Cell Sci     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1065-72     Citation Subset:  IM    
Affiliation:
Department of Tumor Pathology, Karolinska Hospital, Stockholm, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Cycle / drug effects
Cells, Cultured
Culture Media, Serum-Free / pharmacology*
Dolichol / pharmacology*
Fibroblasts / cytology,  drug effects*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Interphase / drug effects*
Lovastatin / pharmacology
Mevalonic Acid / pharmacology*
Proteins / metabolism
Chemical
Reg. No./Substance:
0/Culture Media, Serum-Free; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Proteins; 150-97-0/Mevalonic Acid; 2067-66-5/Dolichol; 75330-75-5/Lovastatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characterization and immunolocalization of RNA polymerase I transcription factor UBF with anti-NOR s...
Next Document:  Very low cadmium concentrations stimulate DNA synthesis and cell growth.